Reed's, INC Form 4 insider transactions

Era Regenerative Medicine Ltd., a significant shareholder and director, has increased its beneficial ownership in REED'S, INC. by acquiring over 1 million shares through a private investment in public equity (PIPE) transaction.

Shufen Deng, a director of Reed's, Inc., transferred ownership of shares held through D&D Source of Life Holding Ltd. to an unaffiliated third party, relinquishing control over those shares.

Shufen Deng, a director and 10% owner of Reed's Inc., acquired 22.4 million shares through a debt-for-equity swap.

Union Square Park Capital Management, along with related entities, sold a portion of their Reed's Inc. common stock holdings in two transactions.

Director John Bello acquired 200,000 shares of Reed's, Inc. common stock through the conversion of a SAFE investment.

Union Square Park Capital Management, LLC and related entities report acquiring 531,205 shares of Reed's, Inc. common stock through the conversion of a SAFE investment.

Deng Shufen, a director and 10% owner of Reed's Inc., has significantly increased her indirect stake in the company through a purchase of 3,268,795 shares at $1.50 per share.

Christopher Burleson, CCO of Reed's Inc., reports the acquisition of stock options and common stock under the company's 2024 Inducement Plan.

CEO Norman E. Snyder, Jr. reports acquisition of Reed's Inc. common stock and non-qualified stock options.

Joann Christine Tinnelly, CFO of Reed's Inc., reports acquisition of common stock and non-qualified stock options.

Director John Bello reports a $300,000 investment in Reed's, Inc. through a Simple Agreement for Future Equity (SAFE), expected to convert into common stock within 60 days.

CFO of Reed's, Inc., John Bello, reports a $300,000 investment in the company through a Simple Agreement for Future Equity (SAFE).